TheProfitWatch

HCWB - HCW Biologics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.37 0.02 (0.46%) --- --- --- 0.13 (2.97%) -0.07 (-1.57%) -0.04 (-0.89%) 0.0 (0.0%)

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-6.79
Diluted EPS:
-6.79
Basic P/E:
-0.6465
Diluted P/E:
-0.6465
RSI(14) 1m:
0.0
VWAP:
4.36
RVol:
0.1658

Events

Period Kind Movement Occurred At
1m Price increase 1m 4.39 +0.05 (+1.15%) Oct 15 15:59
1m Price decrease 1m 4.31 -0.06 (-1.37%) Oct 15 07:30

Related News